NEW YORK, April 02, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Jack Henry & Associates, Inc. (NASDAQ:JKHY), Omnicell, Inc. (NASDAQ:OMCL), Surgery Partners, Inc. (NASDAQ:SGRY), Floor & Decor Holdings, Inc. (NYSE:FND), NVE Corporation (NASDAQ:NVEC), and RA PHARMCTL INC (NASDAQ:RARX), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
JKHY DOWNLOAD: http://Fundamental-Markets.com/register/?so=JKHY
OMCL DOWNLOAD: http://Fundamental-Markets.com/register/?so=OMCL
SGRY DOWNLOAD: http://Fundamental-Markets.com/register/?so=SGRY
FND DOWNLOAD: http://Fundamental-Markets.com/register/?so=FND
NVEC DOWNLOAD: http://Fundamental-Markets.com/register/?so=NVEC
RARX DOWNLOAD: http://Fundamental-Markets.com/register/?so=RARX
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine Jack Henry & Associates, Inc. (NASDAQ:JKHY), Omnicell, Inc. (NASDAQ:OMCL), Surgery Partners, Inc. (NASDAQ:SGRY), Floor & Decor Holdings, Inc. (NYSE:FND), NVE Corporation (NASDAQ:NVEC), and RA PHARMCTL INC (NASDAQ:RARX) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed March 30th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
Jack Henry & Associates, Inc. (JKHY) REPORT OVERVIEW
Jack Henry & Associates' Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, Jack Henry & Associates reported revenue of $374.76MM vs $348.55MM (up 7.52%) and basic earnings per share $2.01 vs $0.76 (up 164.47%). For the twelve months ended June 30th, 2017 vs June 30th, 2016, Jack Henry & Associates reported revenue of $1,431.12MM vs $1,354.65MM (up 5.65%) and basic earnings per share $3.16 vs $3.13 (up 0.96%). Jack Henry & Associates is expected to report earnings on May 1st, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.77. The estimated EPS forecast for the next fiscal year is $3.95 and is expected to report on August 21st, 2018.
To read the full Jack Henry & Associates, Inc. (JKHY) report, download it here: http://Fundamental-Markets.com/register/?so=JKHY
-----------------------------------------
Omnicell, Inc. (OMCL) REPORT OVERVIEW
Omnicell's Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, Omnicell reported revenue of $197.94MM vs $171.98MM (up 15.10%) and basic earnings per share $0.65 vs $0.01 (up 6,400.00%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Omnicell reported revenue of $716.17MM vs $692.62MM (up 3.40%) and basic earnings per share $0.55 vs $0.02 (up 2,650.00%). Omnicell is expected to report earnings on May 3rd, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was -$0.29. The estimated EPS forecast for the next fiscal year is $1.15 and is expected to report on February 7th, 2019.
To read the full Omnicell, Inc. (OMCL) report, download it here: http://Fundamental-Markets.com/register/?so=OMCL
-----------------------------------------
Surgery Partners, Inc. (SGRY) REPORT OVERVIEW
Surgery Partners' Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, Surgery Partners reported revenue of $460.35MM vs $306.00MM (up 50.44%) and basic earnings per share -$1.21 vs $0.36. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Surgery Partners reported revenue of $1,341.22MM vs $1,145.44MM (up 17.09%) and basic earnings per share -$1.64 vs $0.20. Surgery Partners is expected to report earnings on May 8th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.04. The estimated EPS forecast for the next fiscal year is -$0.01 and is expected to report on March 7th, 2019.
To read the full Surgery Partners, Inc. (SGRY) report, download it here: http://Fundamental-Markets.com/register/?so=SGRY
-----------------------------------------
Floor & Decor Holdings, Inc. (FND) REPORT OVERVIEW
Floor & Decor's Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, Floor & Decor reported revenue of $389.50MM vs $278.29MM (up 39.96%) and basic earnings per share $0.53 vs $0.20 (up 165.00%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Floor & Decor reported revenue of $1,384.77MM vs $1,050.76MM (up 31.79%) and basic earnings per share $1.13 vs $0.52 (up 117.31%). Floor & Decor is expected to report earnings on May 24th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.13. The estimated EPS forecast for the next fiscal year is $1.28 and is expected to report on March 7th, 2019.
To read the full Floor & Decor Holdings, Inc. (FND) report, download it here: http://Fundamental-Markets.com/register/?so=FND
-----------------------------------------
NVE Corporation (NVEC) REPORT OVERVIEW
NVE's Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, NVE reported revenue of $7.36MM vs $7.46MM (down 1.37%) and basic earnings per share $0.74 vs $0.72 (up 2.78%). For the twelve months ended March 31st, 2017 vs March 31st, 2016, NVE reported revenue of $28.33MM vs $27.72MM (up 2.20%) and basic earnings per share $2.68 vs $2.53 (up 5.93%). NVE is expected to report earnings on May 2nd, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.62.
To read the full NVE Corporation (NVEC) report, download it here: http://Fundamental-Markets.com/register/?so=NVEC
-----------------------------------------
RA PHARMCTL INC (RARX) REPORT OVERVIEW
RA PHARMCTL INC's Recent Financial Performance
RA PHARMCTL INC is expected to report earnings on May 10th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was -$0.50. The estimated EPS forecast for the next fiscal year is -$2.22 and is expected to report on March 13th, 2019.
To read the full RA PHARMCTL INC (RARX) report, download it here: http://Fundamental-Markets.com/register/?so=RARX
-----------------------------------------
ABOUT Fundamental Markets
Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com
© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.